Publications 2019

Laura García-González, Dominika Pilat, Kévin Baranger, Santiago Rivera. Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience, 2019, 11, ⟨10.3389/fnagi.2019.00244⟩. ⟨hal-02387973⟩
Santiago Rivera. Metalloproteinases in nervous system function and pathology: introduction. Cellular and Molecular Life Sciences, 2019, 76 (16), pp.3051-3053. ⟨10.1007/s00018-019-03172-8⟩. ⟨hal-02387956⟩
Santiago Rivera, Laura García-González, Michel Khrestchatisky, Kevin Baranger. Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences, 2019, 76 (16), pp.3167-3191. ⟨10.1007/s00018-019-03178-2⟩. ⟨hal-02407337⟩
Kévin Baranger, Manuel van Gijsel-Bonnello, Delphine Stephan, Wassila Carpentier, Santiago Rivera, et al.. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer’s Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics, 2019, ⟨10.1007/s13311-019-00754-z⟩. ⟨hal-02339537⟩
Jean-Michel Paumier, Nathalie Py, Laura García-González, Anne Bernard, Delphine Stephan, et al.. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. FASEB Journal, 2019, 33 (2), pp.2910-2927. ⟨10.1096/fj.201801076R⟩. ⟨hal-02387988⟩